Teijin Limited

Teijin Pharma Limited

Reiko Takarada

Satoshi Sugiura

Takaharu Tsutsumi

Yoshiharu Takazawa

Takayuki Hara

Yasunobu Takano

Tomohisa Nakada

Yoshiyuki Matsumoto

Gen Unoki

Yuri Sakai

Hiroko Ogawa

Toshihiro Ishii

Akira Nakano

Masahiro Koga

A compound having GSK-3 inhibitory activity.  Aand Aare a single bond, an aliphatic hydrocarbon group; Aand Aare a single bond, CO, COO, CONR, O, OCO, NR, NRCO, NRCOO, etc.; Gis a single bond, an aliphatic hydrocarbon, aromatic hydrocarbon, heterocyclic; Gis H, an aliphatic hydrocarbon, an alicyclic hydrocarbon, an aromatic hydrocarbon, heterocyclic; Ais a single bond, NR; Ris H, halogen, an aliphatic hydrocarbon, alicyclic hydrocarbon, aromatic hydrocarbon, heterocyclic; Ais a single bond, NR, CO, NRCO, NRCONR, CONR, COO, O, etc.; Ris H, halogen, nitro, saturated aliphatic hydrocarbon, alicyclic hydrocarbon, aromatic hydrocarbon, heterocyclic; and Rmay be a trimethylsilyl, formyl, acyl, carboxyl, alkoxylcarbonyl, carbamoyl, alkylcarbamoyl, or cyano group when Ais CR&#x2550;CR or C&#x2261;C, wherein R is H or an lower aliphatic hydrocarbon group.

Substituted pyrrolo[3,2-d]pyrimidine derivatives

Biphenylamidine derivatives

Growing community of inventors

Hino, Japan

Reiko Takarada